A comparison of complete pathologic response rates following neoadjuvant chemotherapy among South African breast cancer patients with and without concurrent HIV infection.
Sarah NietzDaniel S O'NeilOluwatosin AyeniWenlong Carl ChenMaureen JoffeJudith S JacobsonAlfred I NeugutPaul RuffWitness MapangaInes BuccimazzaUrishka SinghSharon ČačalaLaura StopforthBoitumelo PhakathiTobias ChirwaHerbert CubaschPublished in: Breast cancer research and treatment (2020)
WLWH were less like to achieve pCR following NACT for BC than women without HIV. This reduced response to systemic therapy may contribute to the poorer BC outcomes seen in WLWH.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- antiretroviral therapy
- hiv infected
- hiv positive
- rectal cancer
- human immunodeficiency virus
- lymph node
- sentinel lymph node
- hiv aids
- breast cancer risk
- squamous cell carcinoma
- polycystic ovary syndrome
- hiv testing
- radiation therapy
- hepatitis c virus
- men who have sex with men
- pregnancy outcomes
- type diabetes
- mesenchymal stem cells
- cell therapy
- stem cells
- bone marrow
- real time pcr
- metabolic syndrome
- young adults
- replacement therapy
- childhood cancer
- smoking cessation